Evaluation of MEpolizumab-based Regimen Compared to Conventional Therapeutic Strategy For Remission Induction In Patients With Eosinophilic Granulomatosis With Polyangiitis. Prospective, Randomized, Controlled, Double-blind Study
Latest Information Update: 06 May 2024
At a glance
- Drugs Azathioprine (Primary) ; Cyclophosphamide (Primary) ; Mepolizumab (Primary) ; Prednisone
- Indications Granulomatosis with polyangiitis
- Focus Therapeutic Use
- Acronyms E-merge
- 26 Apr 2024 Planned End Date changed from 1 May 2025 to 1 Nov 2025.
- 26 Apr 2024 Planned primary completion date changed from 1 May 2025 to 1 Nov 2025.
- 28 Jun 2022 Planned End Date changed from 1 Dec 2024 to 1 May 2025.